Neupogen
Showing 1 - 25 of 379
Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)
Recruiting
- Primary Ovarian Insufficiency
- Premature Ovarian Failure
- Neupogen
-
Toronto, Ontario, CanadaTrio Fertility
Oct 31, 2023
Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Nov 20, 2021
Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)
Active, not recruiting
- Lymphoma, AIDS-related
- Lymphoma, Large B-Cell, Diffuse
- Rituximab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Breast Cancer Trial in Bandung (Leucostim 5µg/kg/day, Neupogen 5µg/kg/day)
Completed
- Breast Cancer
- Leucostim 5µg/kg/day
- Neupogen 5µg/kg/day
-
Bandung, IndonesiaRSUP Dr. Hasan Sadikin
Dec 24, 2020
Crohn Disease Trial in Los Angeles (drug, procedure, biological)
Recruiting
- Crohn Disease
- Mesna
- +12 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 23, 2022
Cervix Cancer, Endometrial Cancer Trial in Stanford (FDG PET/CT, GCSF)
Recruiting
- Cervix Cancer
- Endometrial Cancer
- FDG PET/CT
- GCSF
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Feb 11, 2022
Critical Limb Ischemia Trial in Chicago (Pneumatic calf compression, Filgrastim)
Completed
- Critical Limb Ischemia
- Pneumatic calf compression
- Filgrastim
-
Chicago, IllinoisUniversity of Illinois at Chicago
Nov 10, 2021
Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)
Recruiting
- Retinoblastoma
- vincristine
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 25, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,
Recruiting
- Idiopathic Pulmonary Fibrosis
- Emphysema or COPD
- CD3/CD19 negative hematopoietic stem cells
- +6 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Retinoblastoma, Retinal Tumor Trial in Memphis (procedure, drug, radiation, other)
Active, not recruiting
- Retinoblastoma
- Retinal Neoplasm
- Enucleation
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 10, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the
Active, not recruiting
- AIDS-Related Burkitt Lymphoma
- +5 more
- Prednisone
- +7 more
-
Bethesda, MarylandNCI Lymphoid Malignancies Branch
Jul 31, 2022
Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)
Active, not recruiting
- Mantle-Cell Lymphoma
- G-CSF
- +10 more
-
Miami, FloridaUniversity of Miami
Aug 12, 2021
G-CSF Use in Breast Cancer, Lung Cancer, or Lymphoma Treated
Completed
- Breast Cancer
- Lung Cancer
- filgrastim, TBO-filgrastim or pegfilgrastim
- (no location specified)
Jul 24, 2021
Early-stage Breast Cancer Trial in Ottawa (Filgrastim, Pegfilgrastim)
Recruiting
- Early-stage Breast Cancer
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Jun 10, 2021